Skip to content
  • Follow Us

CarboHyde

SUGAR IS LIFE
  • Home
  • About Us
  • Pipeline
  • Technology
  • Investors and Partnering
  • Career
  • CarboHyde News
  • CarboHyde’s Blog
  • Home
  • About Us
  • Pipeline
  • Technology
  • Investors and Partnering
  • Career
  • CarboHyde News
  • CarboHyde’s Blog

CarboHyde

SUGAR IS LIFE
  • Home
  • About Us
  • Pipeline
  • Technology
  • Investors and Partnering
  • Career
  • CarboHyde News
  • CarboHyde’s Blog

Tag: aging

Cyclo Therapeutics Commences Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer’s Disease

Oct 10, 2022Tamas Sohajdadrug developmentaging, alzheimers, cyclodextrin, neurodegenerative diseases

Cyclo Therapeutics, Inc. goes for Phase 2b Study of Trappsol® Cyclo™ for treating early Alzheimer’s disease.
See full post…

Categories

  • carbohydrates
  • drug delivery
  • drug development
  • drug discovery
  • Egyéb kategória
  • news
  • Today's cyclodextrin

Archive

  • March 2023 (36)
  • February 2023 (34)
  • January 2023 (31)
  • December 2022 (23)
  • November 2022 (33)
  • October 2022 (38)
  • September 2022 (9)

Latest posts

  • Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann–Pick Type C Using Quantitative Proteomics
  • A Guide to Your Desired Lipid-Asymmetric Vesicles
  • Grafting of Cyclodextrin to Theranostic Nanoparticles Improves Blood-Brain Barrier Model Crossing

Subscribe to our newsletter

alzheimers analytical chemistry anticancer atherosclerosis cancer research cancer treatment carbohyde cardiovascular chemistry cholesterol clinical trial covid19 cyclodextrin drug delivery formulation development gene therapy glycotime green chemistry infectious diseases monoclonal antibodies neurodegenerative diseases oncology research rare disease scientific advisory board synthesis

Developed by Shuttle Themes. Powered by WordPress.
  • Contact Us
  • LinkedIn
  • Twitter